Cambridge Biomedical Campus
The Cambridge Biomedical Campus
, located at the southern end of Hills Road
on the southern edge of Cambridge
, is one of the largest centres of health science
and medical research
in the world and the largest such centre in Europe
Managed by the University of Cambridge
, the site is funded by organisations such as the Cambridge University Hospitals NHS Foundation Trust
, the Wellcome Trust
, Cancer Research UK
, the UK
government's Medical Research Council
and has National Institute for Health Research
Biomedical Research Centre status. It is an accredited UK academic health science centre
(Cambridge University Health Partners
) and home to Addenbrooke's Hospital
and the university's medical school
The Cambridge Biomedical Campus is home to the following institutes.
Addenbrooke's Hopital is a large teaching hospital, and the central focus of the campus.
Papworth Hospital is due to move to new premises on the Cambridge Biomedical Campus in 2018.
AstraZeneca’s global research and development facility is due to be based on the campus and will house a workforce of approximately 2,000 individuals. It will be home to both early and late-stage medicines discovery and development, and cover both small molecules and biologics. Research activities will span all preclinical functional groups, including antibody engineering, medicinal chemistry and high throughput screening.
The University of Cambridge Medical School, established in 1976.
The LMB is a molecular biology research institute funded by the UK Medical Research Council. It was founded in Cambridge in 1947 as the Unit for Research on the Molecular Structure of Biological Systems and moved to a site adjacent to Addenbrooke's Hospital in 1962. A 27,000m2 replacement building close to the previous site was completed in 2012 and opened in May 2013.
This page was last edited on 29 July 2017, at 15:16.
under CC BY-SA license.